Analysis of Minimized Costs of Stroke Patient Therapy in the Inpatient Facility of A. Wahab Sjahranie Hospital, Samarinda

Raymon Simanullang; Niken Indriyanti; Nurul Anissa

doi:10.59890/ijist.v3i11.208

Authors

Raymon Simanullang Sekolah Tinggi Ilmu Kesehatan Dirgahayu Samarinda Kalimantan Timur
Niken Indriyanti Universitas Mulawarman
Nurul Anissa Universitas Mulawarman

DOI:

https://doi.org/10.59890/ijist.v3i11.208

Keywords:

Ischemic Stroke, Pharmacoeconomics, Retrospektive, Cost Minimization Analysis (CMA), Inpatient.

Abstract

Stroke is a catastrophic disease with a high cost burden. This study aims to analyze the lowest-cost therapy for ischemic stroke patients in the inpatient unit of Abdul Wahab Sjahranie Regional Hospital, Samarinda. The method used was descriptive-retrospective with pharmacoeconomic analysis of Cost Minimization Analysis. Patients were predominantly men aged 40–60 years with a length of stay of 1–5 days. Therapies used included antihypertensives, neuroprotectives, antihyperlipidemics, antidiabetics, and antiplatelets. CMA results showed the lowest cost for amlodipine, citicoline, simvastatin, and metformin, while clopidogrel was the only antiplatelet used. This study provides information on therapy costs that can support the efficiency of stroke treatment.

References

Amarenco, P. et al. 2006. High Dose Atorvastatin After Stroke or Transient Ischaemic Stroke. NEJM Journal Vol. 355 No. 6.

Andersen, K.K., Andersen, Z.J. and Olsen, T.S. 2010. Age and Gender Specific Prevalence of Cardiovascular Risk Factors in 40-102 Patients With First Ever Ischemic Stroke. A Nation wide Danish Study: American Heart Association.

Berisso, M.Z. et al. 2014. Epidemiology of atrial fibrillation : European perspective. Clinical Epidemiology Journal Vol. 6.

Dewanto, G. dkk. 2009. Panduan Praktis Diagnosis dan Tata Laksana Penyakit Saraf. Jakarta: EGC.

Doijad, R.C., Pathan, A.B., Pawar, N.B., Baraskar, S.S., Maske, V.D. dan Gaikwad, S.L. 2012. Therapeutic Applications Of Citicoline And Piracetam As Fixed Dose Combination. Journal of Pharma and Bio Science Vol. 15.

Guijing Wang, PhD., Heesoo Joo, PhD., Xin Tong, MPH., Mary G. George, MD. 2015. Hospital Cost Associated With Atrial Fibrillation for Patients With Ischemic Stroke Aged 18-64 Years in the United States. Stroke Journal of The American Heart Association Vol. 46.

Ismail, Asrul, Nastity Handayany, Gemy, Tantri Nurul Mukmin, Andi. 2017. Pengaruh Penggunaan Obat Piracetam dan Citicoline terhadap Stroke Iskemik di Rumah Sakit Umum Daerah (RSUD) Haji Makassar. Jurnal JF FIK UINAM Vol. 5 No. 1.

James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014. Evidence based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Journal Am Med Assoc Vol. 311 No. 5.

Jeffers BW, Robbins J, Bhambri R, Wajsbrot DA. 2015. Systematic review on the efficacy of amlodipine in the treatment of patients with hypertension with concomitant diabetes mellitus and/or renal dysfunction when compared with other classes of antihypertensive medication. Am Journal Ther Vol. 22 No. 5.

Junaidi, I. 2011. Stroke: waspadai ancamannya.Yogyakarta: Penerbit Andi.

Karuniawati, Hidayah, Zullies Ikawati, Abdul Gofir. 2015. Pencegahan Sekunder Untuk Menurunkan Kejadian Stroke Berulang Pada Stroke Iskemik Volume 5 Nomor 1. Yogyakarta: Fakultas Farmasi Universitas Gadjah Mada.

Kemenkes RI, 2013. Pedoman Penerapan Kajian Farmakoekonomi. Direktorat Jenderal Bina Kefarmasian dan Alat Kesehatan: Kementrian Kesehatan Republik Indonesia Jakarta.

Khalil, O.A. et al. 2013. Prevalence and Pattern of Dyslipidemia in Acute Cerebral Infarction in Medical Intensive Care in Egypt. British Journal of Science Vol.10 No.1.

Martin J. 2008. Hypertension guidelines: Revisiting the JNC 7 recommendations. Journal Lancaster General Hospital Vol. 3 No. 3.

Nufus, H., 2012. Peran Sitikolin untuk Tata Laksana Stroke Iskemik Akut. Medika Jurnal Kedokteran Indonesia Vol. 4, No. 4.

Perhimpunan Dokter Spesialis Saraf Indonesia (PERDOSSI). 2011. Guideline stroke. Jakarta: PERDOSSI.

Praja, Dini Setiya, Didik Hasmono, Nailis Syifa. 2013. Studi Penggunaan Obat Neuroprotektan Pada Pasien Stroke Iskemik Di Rumah Sakit Umum Dr. Saiful Anwar Malang. Pharmacy Malang: Program Studi Farmasi Fakultas Ilmu Kesehatan Universitas Muhammadiyah Malang.

Puspaningtias, J. 2006. Hubungan antara Fibrilasi Atrium dengan Terjadinya Stroke Iskemik pada Pasien Stroke di RSUP dr. Kariadi periode 1 Januari - 31 Desember 2006. Skripsi: Universitas Diponegoro.

Ramadany, A.F, Pujarini,L.A, Candrasari, A. 2013. Hubungan Diabetes Melitus dengan Kejadian Stroke Iskemik di RSUD Dr. Moewardi Surakarta Tahun 2010. Jurnal Biomedika Volume 5 Nomor 2.

Santi, Nur, Zullies Ikawati, Satibi. 2013. Analisis Efektivitas dan Biaya Penggunaan Sitokilin dan Pirasetam pada Pasien Stroke Iskemik di Bangsal Rawat Inap Rumah Sakit. Jurnal Manajemen dan Pelayanan Farmasi Vol. 3, No. 4.

Sitorus, R.J.,Hadisaputro, S., dan Kustiowati, E.. 2008. Faktor-Faktor Risiko Yang Mempengaruhi Kejadian Stroke Pada Usia Muda Kurang dari 40 Tahun Studi Kasus Di Rumah Sakit Di Kota Semarang. Jurnal Epidemiologi Universitas Diponegoro Vol. 1 No.1

Trask, L.S. 2011. Pharmacoeconomics: Principles, Methods, And Applications. China: McGraw-Hill Global Education Holdings LLC.